Cipla Therapeutics and SIGA Technologies Announce Strategic Partnership to support innovation and provide access to novel antibacterial drugs against biothreats Read more
Relief and Acer Therapeutics Sign Collaboration and License Agreement for Worldwide Development and Commercialization of ACER-001 for the Treatment of Urea Cycle Disorders and Maple Syrup Urine Disease Read more
EMA advises against use of ivermectin for the prevention or treatment of COVID-19 outside randomised clinical trials Read more
AZD1222 US Phase III trial met primary efficacy endpoint in preventing COVID-19 at interim analysis Read more
Everest Medicines Announces Acceptance of New Drug Application by China NMPA for Xerava for the Treatment of Complicated Intra-abdominal Infections Read more